Brief: Orgenesis Announces Agreement To Acquire Assets Of Tamir Biotechnology
13/04/2020 13:03
April 13 (Reuters) - Orgenesis Inc ORGS.O :
* ORGENESIS ANNOUNCES AGREEMENT TO ACQUIRE ASSETS OF TAMIR
BIOTECHNOLOGY, INC. INCLUDING BROAD SPECTRUM ANTIVIRAL PLATFORM
* ORGENESIS INC - DEAL FOR STOCK AND CASH CONSIDERATION
VALUED AT
APPROXIMATELY $19 MILLION
* ORGENESIS INC - PLANS TO COMBINE RANPIRNASE WITH ITS
CO-DEVELOPED BIOXOME TECHNOLOGY FOR ENHANCED PAYLOAD DELIVERY
DIRECTLY TO CELLS
Source text for Eikon: ID:nGNX4DKtwf
Further company coverage: ORGS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orgenesis
See all newsBrief: Orgenesis Nasdaq To Delist Co'S Common Stock, Securities Trading Will Be Suspended On Oct 21
Brief: Orgenesis Announces Positive Results From A Real-World Study Of Org-101 Car-T Therapy
Brief: Orgenesis Announces Strategic Partnership With Harley Street Healthcare Group
Brief: Orgenesis Says Entered Purchase Deal With Theracell For Purchase Of 50% Outstanding Ownership Rights & Equity Interests In Theracell Laboratories Ike
Brief: Orgenesis Received Nasdaq Hearings Panel Decision Which Granted Company Until October 14 To Regain Compliance With Bid Price And Equity Rules